Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/SCNI/Capital expenditures

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Capital expenditures 2021–2025

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$24,000FY2025 · since FY2021: $139,000 → $24,000
2122232425
Fiscal yearValueYoY
FY2025$24,000+100.0%
FY2024$12,000-98.1%
FY2023$637,000-23.8%
FY2022$836,000+501.4%
FY2021$139,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More SCNI financial trends

SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →